Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-000480

Director sold 29,350 shares at an average $72.98 ($2,142,089)

  • Director acquired 29,350 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-05 Exercise or conversion : show line 1 in the form 10b5-1 +29,350 $36.75 $1,078,613 33,835.82 D
2024-01-05 Sale : show line 2 in the form 10b5-1 −2,500 $73.46 $183,650 31,335.82 D
2024-01-05 Sale : show line 3 in the form 10b5-1 −26,850 $72.94 $1,958,439 4,485.82 D
Open-market sales · 29,350 sh · avg $72.98 · $2,142,089

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-01-05 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −29,350 $36.75 2024-05-10 29,350 117,400 D
Loading xslF345X05/doc4.xml…